Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph phase_3
1
33%
Ph phase_4
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingphase_4

Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)

NCT07031128
recruitingphase_3

Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial

NCT06646809
recruitingnot_applicable

Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture

NCT04723888

Clinical Trials (3)

Showing 3 of 3 trials
NCT07031128Phase 4

Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)

Recruiting
NCT06646809Phase 3

Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial

Recruiting
NCT04723888Not Applicable

Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3